MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.28 (11.91%)	0.03 (1.15%)	0.17 (6.91%)	-0.12 (-4.36%)	0.28 (11.91%)	-0.01 (-0.75%)	0.9 (67.67%)	1.3 (97.74%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -29.2222
Diluted P/E:: -29.2222
RSI(14) 1m:: 82.05
VWAP:: 2.61
RVol:: 10.0538

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19
1m	Price increase 1m	2.24 +0.12 (+5.66%)	Oct 15 16:19